NEW YORK (GenomeWeb News) – The US Centers for Disease Control and Prevention has expanded a license agreement with Golden Helix for the company’s genetic association software platforms for use in whole-genome association studies, the company said today.
The CDC will use the Golden Helix SNP and Variation Suite, including the HelixTree software for population-based studies, the PBAT software for family-based studies, and the CNAM copy number association tool.
This agreement marks the first time that the CDC has licensed the Golden Helix software for use in its Division of Blood Disorders, the company added.
Financial terms of the agreement were not released.